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The blood-brain barrier (BBB) limits entry of blood-
derived products, pathogens, and cells into the brain
that is essential for normal neuronal functioning and
information processing. Post-mortem tissue analysis
indicates BBB damage in Alzheimer’s disease (AD).
The timing of BBB breakdown remains, however,
elusive. Using an advanced dynamic contrast-
enhanced MRI protocol with high spatial and tempo-
ral resolutions to quantify regional BBB permeability
in the living human brain, we show an age-dependent
BBB breakdown in the hippocampus, a region crit-
ical for learning and memory that is affected early in
AD. The BBB breakdown in the hippocampus and
its CA1 and dentate gyrus subdivisions worsened
with mild cognitive impairment that correlated with
injury to BBB-associated pericytes, as shown by
the cerebrospinal fluid analysis. Our data suggest
that BBB breakdown is an early event in the aging
human brain that begins in the hippocampus and
may contribute to cognitive impairment.
INTRODUCTION
Neuronal computation and normal functioning of the CNS re-
quires tight control of the chemical composition of the neuronal
‘‘milieu’’ that is maintained by the blood-brain barrier (BBB)
(Iadecola, 2004, 2013; Zlokovic, 2008, 2011). Brain endothelial
cells and perivascular mural cells, pericytes, form the BBB,
which limits entry of neurotoxic plasma-derived proteins, circu-
lating metals, pathogens, red blood cells, and leucocytes into
the brain. Studies in murine transgenic models have shown
that a chronic BBB breakdown leads to accumulation of
blood-derived neurotoxic proteins in the CNS including fibrin,
thrombin, hemoglobin, iron-containing hemosiderin, free iron,296 Neuron 85, 296–302, January 21, 2015 ª2015 Elsevier Inc.and/or plasmin (an extracellular matrix-degrading enzyme)
causing progressive neurodegeneration with loss of neurons
mediated by direct neuronal toxicity, oxidant stress, and/or
detachment of neurons from their supporting extracellular matrix
(Daneman et al., 2010; Armulik et al., 2010; Bell et al., 2010, 2012;
Winkler et al., 2012, 2014).
Alzheimer’s disease (AD) is characterized by selective
neuronal vulnerability resulting in progressive loss of memory
(LaFerla, 2012). Post-mortem studies have shown BBB damage
in AD including accumulation in the hippocampus and cortex of
blood-derived proteins (e.g., immunoglobulins, albumin, fibrin-
ogen, and thrombin) (Fiala et al., 2002; Salloway et al., 2002;
Zipser et al., 2007; Ryu and McLarnon, 2009; Hultman et al.,
2013; Sengillo et al., 2013) and degeneration of BBB-associated
pericytes (Sengillo et al., 2013; Farkas and Luiten, 2001; Ba-
loyannis and Baloyannis, 2012). Brain imaging studies have
shown microbleeds and accumulation of iron in AD (Cullen
et al., 2005; Goos et al., 2009; Zonneveld et al., 2014), particu-
larly in the hippocampus (Raven et al., 2013). Some studies using
the cerebrospinal fluid (CSF) to plasma ratio of blood-derived
albumin, reported BBB damage in AD particularly associated
with vascular risk factors (Blennow et al., 1990; Bowman et al.,
2012) or in individuals at a genetic risk for AD (Halliday et al.,
2013). At what stage BBB breakdown occurs in the living human
brain and whether it contributes to cognitive impairment re-
mains, however, controversial.
Here, we used an advanced dynamic contrast-enhanced MRI
(DCE-MRI) and post-processing analysis with improved spatial
and temporal resolutions to quantify the BBB regional perme-
ability Ktrans constant in the living human brain in individuals
with no cognitive impairment (NCI) and mild cognitive impair-
ment (MCI). Compared to a previous approach limited to
measurements of BBB permeability in the white matter (WM)
(Taheri et al., 2011a, 2011b, 2013), the current method allows
simultaneous measurements of BBB Ktrans permeability in
different gray and WM regions. Additionally, we analyzed
CSF biomarkers of BBB breakdown, injury to brain vascular
cells including pericytes and endothelial cells, inflammatory
response, neuronal injury (i.e., tau and pTau), and amyloid
b-peptides (Ab). We found an age-dependent BBB breakdown in
the hippocampus, a region involved in learning and memory
(Squire, 1992) that is damaged early in AD (Braak et al., 1993;
Mu and Gage, 2011; Whitwell et al., 2012). The BBB breakdown
in the hippocampus worsened with MCI that correlated with
measures of injury to BBB-associated pericytes.
RESULTS
NCI andMCI participantswere recruited through theUniversity of
Southern California Alzheimer’s Disease Research Center (USC
ADRC) andHuntingtonMedical Research Institute (HMRI), Pasa-
dena.NCI andMCIparticipantswereevaluatedusing theUniform
Data Set (Morris et al., 2006; Weintraub et al., 2009) and addi-
tional neuropsychological tests asdescribed in theSupplemental
Information. For all participants in this study, the DCE-MRI
procedure was approved by the USC Institutional Review Board
(IRB) and HMRI IRB. Lumbar puncture was approved for older
NCI and MCI participants by the USC IRB and HMRI IRB.
BBB Breakdown in the Hippocampus during
Normal Aging
We studied 12 CNS regions including hippocampus and its
subdivisions CA1, CA3, and dentate gyrus (DG), different
cortical regions, subcortical regions (e.g., thalamus, striatum,
and caudate nucleus), and theWM regions including corpus cal-
losum and internal capsule (Figures 1A and 1B) and generated
regional Ktrans BBB permeability maps for each individual using
a modified Patlak linearized regression mathematical analysis
(Patlak and Blasberg, 1985) (Figure 1C). We determined in
each individual the arterial input function (AIF) from the common
carotid artery instead of using an average value from the superior
sagittal venous sinus to determine tracer concentration in blood
(Taheri et al., 2011a, 2011b, 2013; Larsson et al., 2009). Individ-
ual AIF measurements are important particularly if the studied
population diverges by age as changes in blood volume and
flow may affect AIF and the Ktrans measurements.
Unexpectedly, we found that NCI individuals (Table 1) have an
age-dependent progressive loss of BBB integrity in the hippo-
campus, as shown by an age-dependent increase in the Ktrans
values in the entire hippocampus, its CA1 region, and DG, but
not the CA3 region (Figures 1D–1G). No significant BBB changes
during aging were found in cortical (e.g., frontal cortex, temporal
cortex) or subcortical (e.g., thalamus, striatum) regions except
for the caudate nucleus (Figures S1A–S1E). Surprisingly, we
did not find significant age-dependent changes in the BBB in
subcortical WM fibers, corpus callosum, and internal capsule
(Figures S1F–S1H), even though WM is believed to be affected
by vascular changes early in AD (Iadecola, 2013; Yoshita et al.,
2006). Collectively, our data suggest that early vascular leakage
in the aging human brain begins in the hippocampus, which
normally shows the highest barrier properties (i.e., the lowest
Ktrans values) compared to other brain regions.
Accelerated BBB Breakdown in the Hippocampus
in Individuals with MCI
Next, we compared the BBB permeability in young NCI and
older NCI (both CDR = 0) and MCI (CDR = 0.5) groups (Figure 2;Table 1). We found a significant increase in the BBB permeability
Ktrans values in the hippocampus (Figure 2A) and its CA1 and DG
regions, but not CA3, by 41%, 107%, and 48% in the older
compared to the young NCI group and by 24%, 53%, and
27% in MCI compared to age-matched older NCI controls,
respectively (Figures 2B–2E). In contrast, there were no signifi-
cant differences in the BBB permeability in cortical, subcortical,
and WM regions between young and older NCI and/or MCI and
age-matched older NCI participants (Table S1), except for an
increase in the caudate nucleus in older compared to young
NCI group. We did not find significant changes in hippocampal
volumes between the studied groups determined on coronal
T2-weighted MRIs (Figure 3).
To validate our method, we studied multiple sclerosis (MS)
cases with established BBB breakdown in the WM, as reported
(Taheri et al., 2011b), as an additional neurological control. MS
cases had a diagnosis of the relapsing remitting MS and met
McDonald Criteria (Polman et al., 2011). We selected younger
MS cases without cognitive complaints that were age-matched
to younger NCI controls (Table 1). The MS patients did not
show changes in the Ktrans values in the hippocampus or hippo-
campal subregions (Figures 2B–2E), or in other CNS gray matter
regions (Table S1). They had, however, increased BBB perme-
ability in the total WM, corpus callosum, and internal capsule
compared to age-matched younger NCI group by 32%, 26%,
and 23% (p < 0.001), respectively (Table S1), consistent with
the reported BBB alterations in the WM in MS (Taheri et al.,
2011b). Our data extend importantly previous findings by
showing no changes in the BBB integrity in the hippocampus
and other studied gray matter regions in MS.
Molecular Biomarker CSF Analysis
A significant 30% increase in the CSF/plasma albumin ratio
(Blennow et al., 1990; Bowman et al., 2012; Halliday et al.,
2013) additionally confirmed BBB breakdown in MCI individuals
compared to age-matched NCI controls (Figure S2A). The
increase in the CSF/plasma albumin ratio correlated with an
increase in the Ktrans values in the hippocampus and its CA1
and DG subregions (Figures S2B–S2D) that showed an increase
in the BBB permeability in MCI compared to age-matched NCI
controls (Figures 2B, 2C, and 2E).
Next, we studied correlations between Ktrans values and CSF
levels of soluble platelet-derived growth factor receptor b
(sPDGFRb). PDGFRb is an established marker of the BBB-
associated pericytes (Armulik et al., 2010; Bell et al., 2010,
2012; Winkler et al., 2011) that play a key role in maintaining
the BBB integrity (Zlokovic, 2008, 2011; Iadecola, 2013; Dane-
man et al., 2010; Armulik et al., 2010; Bell et al., 2010, 2012; Win-
kler et al., 2012). Pericytes degenerate in AD (Sengillo et al.,
2013; Farkas and Luiten, 2001; Baloyannis and Baloyannis,
2012) and have a key role in BBB clearance of Alzheimer’s toxin
amyloid b-peptide (Ab) (Sagare et al., 2013). Pericytes die when
Ab intracellular accumulation overrides their Ab clearance capa-
bility (Sagare et al., 2013) and when exposed to hypoxia. Here,
we show that both severe hypoxia (Bell et al., 2009) and Ab are
associated with shedding of the soluble form of the receptor
(sPDGFRb) from primary human cultured pericytes (Zhu et al.,
2010) (Figures S3A–S3D). Furthermore, sPDGFRb levels wereNeuron 85, 296–302, January 21, 2015 ª2015 Elsevier Inc. 297
Figure 1. Blood-Brain Barrier Breakdown in the Hippocampus in the Living Human Brain during Normal Aging
(A and B) A dynamic contrast enhancedMRI was used to quantify the blood-brain barrier (BBB) regional permeability Ktrans constant in 12 regions of interest in the
gray and white matter in the living human brain (A) including subdivisions of the hippocampus (B). (C) Representative BBB Ktrans maps of the whole brain (left) and
the hippocampus (right) in a young participant with no cognitive impairment. (D–G) Age-dependent increase in the BBB permeability Ktrans constant in the entire
hippocampus, its CA1 region, and dentate gyrus, but not CA3 region. Single data points for the Ktrans constant from 24 individuals with no cognitive impairment
(both genders, ages 23–91; see Table 1) were plotted against age; r = Pearson’s coefficient; p, significance; NS, non-significant. See also Figure S1.
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Table 1. Participants’ Demographic Information
NCI, Young NCI, Older MCI MS
Clinical Dementia
Rating scale
0 0 0.5 0
Number of participants 6 18 21 19
Female 50% 55.6% 52.4% 63.2%
Age range 23–47 55–91 55–85 26–53
DCE-MRI 6/6 18/18 20/21 19/19
Lumbar puncture 0/6 15/18 17/21 0/19
Age at lumbar puncture,
Mean (SD)
N/A 73.2 (10.6) 72.0 (8.5) N/A
NCI, no cognitive impairment; MCI, mild cognitive impairment; MS,
multiple sclerosis; DCE-MRI, dynamic contrast-enhanced MRI; SD,
standard deviation; N/A, not applicable.increased by 115% in MCI compared to age-matched NCI con-
trols (Figure 4A). There was a positive correlation between
sPDGFRb CSF levels and the Ktrans values in the hippocampusFigure 2. Blood-Brain Barrier Breakdown in the Hippocampus during N
(A) Representative Ktrans maps within the hippocampus in young and older indivi
MS, a multiple sclerosis case with no cognitive impairment. (B–E) A progressive
young NCI group and MCI compared to older NCI group in the entire hippocampu
young NCI group. Boxplots represent the median (dark horizontal line), with the
percentiles. p, significance by ANOVA followed by Tukey’s post hoc tests; NS, no
ages 55–91, both genders); MCI (n = 20, ages 55–85, both genders); MS (n = 19including its CA1 and DG subdivisions (Figures 4B–4D) that
showed increased BBB permeability in MCI compared to NCI in-
dividuals (Figures 2B, 2C, and 2E).
To validateCSF sPDGFRb as amarker of pericyte injury in vivo,
we studied sPDGFRb CSF levels in 16-month-old pericyte-defi-
cient Pdgfrb+/ mice, which develop 45%–50% loss of brain
pericytes (Bell et al., 2010), and 16-month-old Alzheimer’s
Tg2576 mice, which develop an age-dependent pericyte loss
from 17% at 9 months of age (Sagare et al., 2013) to 35% at
18 months of age (Park et al., 2013). There was a significant
289% and 58% increase in sPDGFRb CSF levels in Pdgfrb+/
mice and Tg2576 mice, respectively, compared to their corre-
sponding littermate controls (Figures 4E and 4F), indicating
that sPDGFRb is a reliable CSFmarker of pericytes injury inmice.
The CSF analysis revealed no injury to other cell types in the
neurovascular unit (Iadecola, 2004; Zlokovic, 2008, 2011) in
NCI or MCI including endothelial cells as shown by unaltered
CSF levels of biomarkers of endothelial cell injury such as soluble
intercellular adhesion molecule-1 (sICAM-1) and vascular cell
adhesion molecule-1 (sVCAM-1) (Iadecola, 2004; Zlokovic,ormal Aging and Aging Associated with Mild Cognitive Impairment
duals with no cognitive impairment (NCI) and mild cognitive impairment (MCI).
significant increase in the BBB permeability constant Ktrans in older compared
s, CA1 region, and dentate gyrus. MS group was compared with age-matched
box representing the 25th and 75th percentiles, the whiskers the 5th and 95th
n-significant. NCI, young (n = 6, ages 23–47, both genders); NCI, older (n = 18,
, ages 26-53, both genders). See Table 1 and Figure S2.
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Figure 3. Hippocampus Volume in the Studied Groups
Hippocampus volume was determined on T2-weighted images in individuals
with no cognitive impairment (NCI), with mild cognitive impairment (MCI), and
multiple sclerosis (MS) cases with no cognitive impairment. Boxplots repre-
sent the median (dark horizontal line), with the box representing the 25th and
75th percentiles, the whiskers the 5th and 95th percentiles. NS, non-significant
by ANOVA followed by Tukey’s post hoc tests. NCI, young (n = 6, ages 23–47,
both genders); NCI older (n = 18, ages 55–91, both genders); MCI (n = 20, ages
55–85, both genders); MS (n = 19, ages 26–53, both genders). See Table 1.2008); no change in the inflammatory response as shown by un-
altered CSF levels of several studied cytokines (e.g., interleukins
IL-2, IL-6, and IL-8, tumor necrosis factor-a, and interferon-g); no
change in neuronal injury (e.g., tau and pTau) and Ab (e.g., Ab38,
Ab40, and Ab42); and no change in matrix metalloproteinase-9
that is involved in degradation of the BBB tight junction and300 Neuron 85, 296–302, January 21, 2015 ª2015 Elsevier Inc.the basement membrane proteins of the vessel wall (Bell et al.,
2012; Halliday et al., 2013) (Figure S4).DISCUSSION
We developed an advanced DCE-MRI approach and post-pro-
cessing analysis resulting in improved spatial resolution and
signal-to-noise ratio (SNR) of the Ktrans BBB maps with the anal-
ysis of the arterial input function in each individual allowing for
accurate measurements of the regional BBB permeability in
the living human brain in different gray and WM regions. For
example, our high-resolution hippocampal imaging allows for
characterization of the Ktrans BBB values not only in the hippo-
campus, but also in the hippocampal subfields. In comparison,
studies on the blood-brain tumor barrier permeability (Larsson
et al., 2009) or BBB in stroke (Aksoy et al., 2013) do not generally
require spatial resolution or SNR as high as the present study, as
changes in the barrier permeability in brain tumors or after stroke
are typically one order of magnitude or more higher than the
presently measured BBB changes during normal aging, aging
associated with MCI, and/or possibly other neurodegenerative
conditions. The BBB permeability Ktrans values in the hippocam-
pus and cortex and other brain regions in young NCI individuals
were within a range of previously reported BBB Ktrans values
to small inert polar molecules in mammals including rodents
(Zlokovic, 2011; Bell et al., 2010; Deane et al., 2003).
We show that the BBB breakdown during normal aging occurs
initially in the hippocampus, a region critical for learning and
memory. The BBB breakdown was more pronounced in MCI
compared to age-matched neurologically intact controls, raisingFigure 4. Soluble Platelet-Derived Growth
Factor Receptor b in theCerebrospinal Fluid
in Humans and Mice
(A) Elevated sPDGFRb levels in the CSF in
individuals with mild cognitive impairment (MCI;
n = 17) compared to age-matched group with no
cognitive impairment (NCI, older; n = 14). Boxplots
represent the median (dark horizontal line), with
the box representing the 25th and 75th percentiles,
the whiskers the 5th and 95th percentiles. (B–D)
Single data points for sPDGFRb CSF levels from
31 individuals with NCI (n = 14, black) or MCI (n =
17, red) plotted against the Ktrans constant in the
hippocampus (B), its CA1 region (C), and dentate
gyrus (D); r = Pearson’s coefficient; p, significance.
(E and F) sPDGFRb CSF levels in 16-month-old
Pdgfrb+/ mice and Pdgfrb+/+ controls (C) and
16-month-old Tg2576 mice compared to age-
matched littermate controls (D). Boxplots repre-
sent the median (dark horizontal line), with the
box representing the 25th and 75th percentiles, the
whiskers the 5th and 95th percentiles. In (C) and (D),
n = 5 mice per group. p, significance by a
Student’s t test. See also Figures S3 and S4.
a possibility that it might contribute to early cognitive impair-
ment. Interestingly, our data show that the BBB integrity in
other brain regions including cortical and subcortical regions or
the WM remains relatively unaffected during normal aging or
aging associated with MCI. Although we did not find significant
changes in hippocampal volumes between the young and
older NCI and MCI individuals, it is possible that an early and
progressive increase in the BBB permeability, as we show in
the hippocampus in older NCI and MCI individuals, might pre-
cede hippocampal atrophy seen later in AD (Whitwell et al.,
2012; Apostolova et al., 2010), particularly in MCI progressing
to AD. This would be similar to findings in animal models with a
chronic BBB disruption showing that vascular leakages over
time lead to hippocampal and cortical atrophy, loss of neurons,
and progressive behavioral changes (Bell et al., 2010, 2012;
Winkler et al., 2012, 2014).
Findings in murine models of a small vessel brain disease
(Daneman et al., 2010; Armulik et al., 2010; Bell et al., 2010,
2012) and human post-mortem AD studies (Fiala et al., 2002;
Salloway et al., 2002; Zipser et al., 2007; Ryu and McLarnon,
2009; Hultman et al., 2013; Sengillo et al., 2013) have shown
that BBB breakdown leads to tissue accumulation of potentially
neurotoxic blood-derived products that normally do not enter the
brain but can damage neurons when the vessels become leaky.
We show that pericyte injury and possibly early degeneration
correlates with increased BBB permeability within the hippo-
campus, a region known to be affected by pericyte loss and
BBB breakdown on post-mortem tissue analysis in AD (Sengillo
et al., 2013). Although, our CSF biomarkers analysis did not
show endothelial cell injury, involvement of inflammatory cyto-
kines, and/or direct vasculotoxic effects of Ab in MCI, it is
possible that some of these factors could play a role in magni-
fying BBB damage at later disease stages during progression
to dementia due to AD, as they all were shown to alter BBB
permeability in experimental models (Zlokovic, 2011).
In summary, our data suggest loss of cerebrovascular integrity
during normal aging and aging associated with MCI that begins
in the hippocampus which may contribute to early stages of
dementia associated with AD.EXPERIMENTAL PROCEDURES
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